Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $38.47
Latest analyst grade actions
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 50.98 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 44.60 | Oscillator | Neutral |
| Williams %R (14) | -34.66 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.17 (Hist -0.12) | Oscillator | Strong Sell |
| Average Directional Index (14) | 13.24 (+DI 15.7 / -DI 13.2) | Trend | Neutral |
| EMA 20 | 38.05 | MA | Buy |
| SMA 20 | 38.19 | MA | Buy |
| EMA 50 | 38.69 | MA | Sell |
| SMA 50 | 38.04 | MA | Buy |
| SMA 200 | 41.61 | MA | Strong Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 23, 2026 | 0.34 | 0.42 | Beat 22.8% | $1.54B |
| Jul 31, 2026 | 0.31 | 0.34 | Beat 7.0% | $1.42B |
| Apr 24, 2026 | 0.30 | 0.34 | Beat 11.3% | $1.48B |
| Jan 26, 2026 | 0.28 | 0.25 | Miss -9.1% | $1.38B |
| Oct 31, 2025 | 0.27 | 0.30 | Beat 13.0% | $1.43B |
| Jul 25, 2025 | 0.25 | 0.28 | Beat 14.0% | $1.36B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| F-6EF | Oct 20, 2026 | 2026-10-20 10:09:00 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | FANUF | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 26.1x | 28.2x · sector 18.4x | Elevated |
| Forward P/E (FY27E) | 0.2x | EPS est. 227.05 | Discount |
| Price / Book | 2.7x | 2.6x | In line |
| Price / Sales | 5.6x | 5.4x | In line |
| EV / EBITDA | 15.5x | 17.4x | In line |
| Return on equity | 10.7% | — | Healthy |
| Gross margin | 39.7% | 37.7% | In line |
| Debt / Equity | 0.00 | 0.00 | Conservative |
| Piotroski / Altman Z | 5/9 | Z 17.45 | Safe zone |
Discounted cash flow model